Summary & Overview
CPT 0950T: Transrectal HIFU Ablation of Benign Prostate Tissue
CPT code 0950T represents transrectal high intensity–focused ultrasound (HIFU) ablation of benign prostate tissue under ultrasound guidance. The code captures a minimally invasive, image-guided prostate procedure increasingly considered as an alternative to other surgical and device-based benign prostatic hyperplasia (BPH) treatments. Nationally, adoption of HIFU has implications for procedural pathways, outpatient capacity, and payer coverage policies as technology-driven, tissue-preserving options expand.
Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a grounded summary of what the code denotes clinically, typical sites of service, and which major payers are relevant to coverage and reimbursement conversations. The publication also outlines the kinds of benchmarks and policy updates readers can expect: utilization and reimbursement benchmarking, common modifiers and billing considerations, and the clinical context for use in patients with benign prostate conditions.
This summary is written for a national audience seeking concise policy and billing context for CPT code 0950T, including stakeholders involved in coding, billing strategy, coverage policy, and clinical program planning.
Billing Code Overview
CPT code 0950T describes a high intensity–focused ultrasound (HIFU) procedure performed transrectally to ablate benign prostate tissue under ultrasound guidance. The service is a minimally invasive thermal ablation therapy delivered via a device inserted through the rectum while real-time ultrasound imaging guides targeting and monitoring of tissue destruction.
Service type: Image-guided transrectal HIFU prostate ablation
Typical site of service: Outpatient ambulatory surgery center or hospital outpatient department, with possible performance in other outpatient procedural settings depending on facility capability and payer rules.
Clinical & Coding Specifications
Clinical Context
A typical patient is a man in his 60s to 70s with symptomatic benign prostatic hyperplasia (BPH) who has persistent lower urinary tract symptoms (urinary frequency, nocturia, weak stream, incomplete emptying) despite medical therapy (alpha-blockers and/or 5-alpha-reductase inhibitors) or who desires a minimally invasive alternative to transurethral resection. The procedure is performed in an outpatient ambulatory surgery center or hospital outpatient department. Pre-procedure evaluation includes urologic history, physical exam with digital rectal exam, prostate-specific antigen testing, urinalysis to exclude infection, and transrectal ultrasound or MRI to assess prostate volume and anatomy. On the day of service the patient receives appropriate anesthesia (conscious sedation, regional block, or general anesthesia per anesthesiology and patient comorbidity). Under ultrasound guidance, a high intensity–focused ultrasound (HIFU) device is inserted transrectally; targeted sonication destroys localized benign prostate tissue. Intra-procedural ultrasound imaging is used to monitor treatment area and avoid adjacent structures. Post-procedure monitoring includes voiding trial, pain management, and instructions regarding urinary catheter use if placed. Follow-up visits assess symptom improvement, urinary flow, post-void residual, and PSA trends. Typical site of service: outpatient ambulatory surgery center or hospital outpatient department. Service type: minimally invasive image-guided prostate ablation procedure using transrectal HIFU.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when substantial additional work, time, or effort is required beyond typical HIFU ablation (document rationale and value of increased complexity). |
51 | Multiple procedures | Use when another unrelated surgical procedure is performed in the same session; primary procedure should be identified per payer rules. |
52 | Reduced services | Use when HIFU is intentionally partially completed or scope is reduced but still performed. |
53 | Discontinued procedure | Use when procedure is started but terminated for patient safety or unforeseen complication; document reason for discontinuation. |
54 | Surgical care only | Use when another clinician provides pre- and post-operative care while surgeon performs only the intraoperative portion. |
55 | Postoperative management only | Use when provider furnishes only postoperative care after another surgeon performed the HIFU. |
56 | Preoperative management only | Use when provider performs only preoperative evaluation and optimization and does not perform the HIFU. |
62 | Two surgeons | Use when two surgeons with different skills are required and both actively participate in the HIFU procedure. |
66 | Surgical team (multiple surgeons) | Use when a surgical team approach is used and team reporting is allowed by payer. |
78 | Return to OR for related procedure during global period | Use when the patient returns to the operating room for a related procedure or complication after the initial HIFU during the global period. |
79 | Unrelated procedure or service by same physician during global period | Use when an unrelated procedure is performed by the same physician during the global period (not in the provided list but commonly relevant; not included above). |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
2080S0001X | Urology | Urologists commonly perform transrectal HIFU ablation for BPH. |
207L00000X | Interventional Radiology | Interventional radiologists may be involved when image-guidance expertise is required. |
2084P0800X | Radiation Oncology | Radiation oncologists are less commonly involved but may have HIFU programmatic oversight in some centers. |
364S00000X | Anesthesiology | Anesthesiologists or CRNAs provide procedural sedation or general anesthesia for HIFU cases. |
261QM0800X | Family Medicine | In some outpatient programs primary care or family medicine physicians coordinate pre- and post-procedure care. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
N40.0 | Enlarged prostate with lower urinary tract symptoms | Primary indication for transrectal HIFU ablation to relieve obstructive BPH symptoms. |
N40.1 | Nodular prostate without lower urinary tract symptoms | May be considered when nodularity causes progressive changes or as part of evaluation leading to treatment decision. |
R33.9 | Retention of urine, unspecified | Acute or chronic urinary retention can be an indication for procedural intervention when refractory to medical therapy. |
R39.15 | Urgency of urination | Symptom commonly reported by patients with BPH considered when selecting HIFU therapy. |
N13.8 | Other obstructive and reflux uropathy | Relevant when bladder outlet obstruction from BPH leads to upper urinary tract effects and requires definitive therapy. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
52000 | Cystourethroscopy, with or without irrigation and with or without diagnostic procedures; diagnostic, with or without collection of specimen(s) by brushing or washing | Performed preoperatively or intraoperatively to evaluate the urethra and bladder, or postoperatively if hematuria or retention occurs. |
51701 | Insertion of temporary indwelling urethral catheter; simple (e.g., straight catheterization) | May be used intraoperatively or postoperatively for bladder drainage or voiding trial. |
76942 | Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | Used for ultrasound guidance and documentation when imaging guidance is billed separately according to payer policy. |
52332 | Cystoscopy, with manipulation of ureteral orifice, including dilation and/or stent placement | Performed if ureteral compromise or need for stent placement arises from procedure-related issues. |
99499 | Unlisted evaluation and management service | Used for reporting unusual pre- or post-procedure evaluation services not described by another code when necessary (use per payer rules). |